Evidence map›Paper›PMID 35204756›Full record

ReviewBiomolecules2022

Glycosylating Effectors of

Yury Belyi, Nadya Levanova, Gunnar N Schroeder

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Journal of bacteriology · 2024
    Review
  3. Article
  4. Article
  5. Insights into the role of legionella effectors on host metabolic perturbations.Frontiers in cellular and infection microbiology · 2024
    Review
  6. Biomolecules · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Yury BelyiLaboratory of Molecular Pathogenesis, Gamaleya Research Centre, 123098 Moscow, Russia.ORCID 0000-0003-2312-1465
Nadya LevanovaStockert GmbH, D-79111 Freiburg, Germany.
Gunnar N SchroederWellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7BL, UK.ORCID 0000-0002-0412-7741
Gamalei Institute of Epidemiology and Microbiology · RUQueen's University Belfast · GB

Funding

Biotechnology and Biological Sciences Research Council BB/W002752/1
6 · The paper itself

Abstract

Work over the past two decades clearly defined a significant role of glycosyltransferase effectors in the infection strategy of the Gram-negative, respiratory pathogen

Indexed as

Legionella pneumophilaBacterial ProteinsGlucosyltransferasesHost-Pathogen InteractionsProtein BiosynthesisBacterial ProteinsGlucosyltransferaseseffector glycosyltransferasehost manipulationintracellular pathogenLegionella pneumophilatype 4 secretion systemvirulence mechanism

Identifiers

PMID35204756
PMCPMC8961657
OpenAlexW4210679754

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.